Reappraisal (reconstruing emotional experiences to alter their impact) and suppression (inhibiting emotionally expressive behavior) are emotion-regulation strategies with important implications for depression. While reappraisal generally predicts lower depressive symptoms, suppression generally predicts higher depressive symptoms. Because cultural factors can influence the processes involved in these links and because adolescence-especially for ethnic minority youth-brings particular emotional challenges, it's critical to investigate these links among Mexican-origin adolescents. However, research examining emotion regulation among Mexican-origin individuals is scarce and generally limited to cross-sectional designs. Thus, we examined prospective associations between reappraisal and suppression (assessed at age 17) and 2 facets of depressive symptoms (anhedonia and general distress) over 3 years (assessed at ages 16, 18, and 19) among 228 Mexican-origin adolescents. Latent growth curve models indicated that reappraisal was associated with lower anhedonia at baseline (age 16) and lower anhedonia over time, whereas suppression predicted greater anhedonia at baseline but not change over time. Consistent with the Mexican cultural value of which emphasizes expressing positive emotions and inhibiting negative emotions, suppression of emotions was associated with anhedonia over time whereas suppression of emotions was associated with anhedonia over time. However, neither associated with anhedonia at baseline. Reappraisal and suppression were not associated with distress symptoms, and no effects were moderated by familism, household income, gender, or child nativity. The anhedonia results suggest that the benefits of reappraisal extend to Mexican-origin adolescents, but the effects of suppression may depend upon emotional valence in this group. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644291 | PMC |
http://dx.doi.org/10.1037/emo0001060 | DOI Listing |
Trials
January 2025
Center for Research in Neuropsychology and Cognitive and Behavioral Intervention, Faculty of Psychology and Education Sciences, University of Coimbra, Coimbra, Portugal.
Background: Breast cancer is the most diagnosed cancer in women worldwide and carries a considerable psychosocial burden. Interventions based on Acceptance and Commitment Therapy (ACT) and compassion-based approaches show promise in improving adjustment and quality of life in people with cancer. The Mind programme is an integrative ACT and compassion-based intervention tailored for women with breast cancer, which aims to prepare women for survivorship by promoting psychological flexibility and self-compassion.
View Article and Find Full Text PDFHealth Qual Life Outcomes
January 2025
Department of Human Sciences, LUMSA University, Rome, 00193, Italy.
Background: The number of people living with congenital heart disease (CHD) in 2017 was estimated to be 12 million, which was 19% higher than that in 1990. However, their death rate declined by 35%, emphasizing the importance of monitoring their quality of life due to its impact on several patient outcomes. The main objective of this study is to analyze how parents' psychosocial factors contribute to children's and adolescents' perceptions of their QoL, focusing on their medical condition.
View Article and Find Full Text PDFBMC Psychiatry
January 2025
MedaData, LLC, Rochester Hills, USA.
Background: Adults with ADHD benefit from treatment with extended-release (ER) formulations that provide symptom control for the entire day. Some patients are advised to supplement their extended-release medication with an immediate-release (IR) medication later in the day if they need to prolong its effects. Given that several FDA-approved ER formulations are available and many individual patient variables may affect efficacy, the purpose of this study was to identify reliable predictors of the tendency for patients to supplement their daily ER medication with an IR medication.
View Article and Find Full Text PDFBMC Health Serv Res
January 2025
VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, CA, USA.
Background: 2022 survey data showed 29% of Veterans utilized Veterans Affairs (VA) paid health care at a non-VA facility, 6% higher than in 2021. Despite an increase in the number of Veterans accessing care in the community via the MISSION Act Community Care Program (CCP), there is limited information on the quality of mental health care delivered to Veterans in these settings. Further, Veterans report barriers to quality care, including poor communication between CCP and VA providers, which can result in negative patient outcomes.
View Article and Find Full Text PDFBMC Psychiatry
January 2025
Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran.
Introduction: Mental disorders, such as anxiety and depression, significantly impacted global populations in 2019 and 2020, with COVID-19 causing a surge in prevalence. They affect 13.4% of the people worldwide, and 21% of Iranians have experienced them.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!